10-K/A

AMENDMENT NO. 1 TO FORM 10-K

Company: Denali Therapeutics Inc.
Filed: July 13, 2018
Period of Report: December 31, 2017
Accession Number: 0001193125-18-217923

View Document ↗ View on SEC.gov ↗